4Filing Date: Aug 18, 2026

Hims & Hers Health

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001773751-26-000205
Total Value$0
Trades3
Insiders1

Transaction Details

Payne Christopher D
Director·Direct
Exercise · Acquire
Class A Common Stock
Shares+545
Price-
Total Value$0
Shares Owned After34.86K
Transaction DateAug 14, 2026
Footnotes ▸

The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.

Payne Christopher D
Director·Direct
Exercise · Dispose
Restricted Stock UnitDerivative
Shares-545
Price$0.00
Total Value$0
Shares Owned After0
Transaction DateAug 14, 2026
Footnotes ▸

The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. | The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. | The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date.

Payne Christopher D
Director·Indirect · Held by The Payne Family Trust dtd 09/17/2020
Class A Common Stock
Shares0
Price-
Total Value$0
Shares Owned After110.00K

Post-Transaction Holdings

Payne Christopher D · Director
SecuritySharesChange
Class A Common Stock144.86K+545 (0.38%)
Restricted Stock Unit0-545 (-100.00%)
auto_awesome

Deep Analysis

Director Christopher D. Payne exercised 545 RSUs and did not sell a single share — a passive, compensation-driven increase, not an active buy signal.

lock
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-08-14 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: Hims & Hers Health, Inc. (HIMS) CIK: 0001773751 --- Reporting Owner --- Name: Payne Christopher D CIK: 0001612163 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Class A Common Stock Date: 2026-08-14 | Code: M (Exercise of derivative) Shares: +545 Shares Owned After: 34,863 | Ownership: D (Direct) Footnotes: [F1] The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. --- Derivative Transactions --- [Transaction #1] Security: Restricted Stock Unit Date: 2026-08-14 | Code: M (Exercise of derivative) Shares: -545 | Price: $0.00 Shares Owned After: 0 | Ownership: D (Direct) Footnotes: [F1] The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. [F1] The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. [F1] The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. --- Holdings --- [Holding #1] Security: Class A Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: The Reporting Person was granted Restricted Stock Units ("RSUs") which represent a contingent right to receive one share of Class A Common Stock for each RSU. The RSUs were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy, in lieu of the director retainer fee for the second quarter of 2026. The number of RSUs granted was calculated by dividing the foregone cash fees of $16,598 by the grant price of $30.40. The RSUs will vest in full on the Company's next quarterly vesting date. --- Signature --- /s/ /s/ Kimberly Mather, Attorney-in-Fact for Christopher D Payne (2026-08-18)

keid analysis is for reference only and does not constitute investment advice.